Immunization issues before and after solid organ transplantation in children

Pediatric Transplantation

Volumn 10, Issue 5, 2006, Pages 536-548

  Verma, Anita ^a   Wade, Jim J ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Immune response; Immunization; Immunosuppression; Solid organ transplantation; Vaccine

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE;

ANTIBODY RESPONSE; DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; GRAFT VERSUS HOST REACTION; HEPATITIS A; HEPATITIS B; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPROPHYLAXIS; INFECTION RISK; INFECTIOUS COMPLICATION; INFLUENZA; ORGAN TRANSPLANTATION; PASSIVE IMMUNIZATION; PERTUSSIS; RECIPIENT; REVIEW; STREPTOCOCCUS PNEUMONIA; TETANUS; TREATMENT CONTRAINDICATION;

CHILD; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; VACCINATION;

EID: 33745699205     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00527.x     Document Type: Review

References (106)

1. KAPLAN L, DAUM R, SMARON M, MCCARTHY C. Severe measles in immunocompromised patients. JAMA 1992: 267: 1237-1241.
2. FITTS S, GREEN M, REYES J, NOUR B, TZAKIS A, KOCOSHIS S. Clinical features of nosocomial rotavirus infection in pediatric liver transplant recipients. Clin Transplant 1995: 9: 201-204.
3. MCGREGOR R, ZITELLI B, URBACH A, MALATACK J, GARTNER J. Varicella in pediatric orthotopic liver transplant recipients. Pediatrics 1989: 83: 256-261.
4. STRARK K, GUNTHER M, SCHONFELD C, TULLIUS SG, BIENZIE U. Immunisations in solid-organ transplant recipients. Lancet 2002: 359: 957-965.
5. BURROUGHS M, MOSCONA A. Immunisation of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000: 30: 857-869
6. DUCHINI A, GOSS JA, KARPEN S, POCKROS PJ. Vaccinations for solid organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003: 16: 357-364.
7. LOPEZ JM, THOMAS S. Immunisations of children after solid organ transplantation. Pediatr Clin N Am 2003: 50: 1435-1449.
8. Anonymous. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplantation 2004: 4(Suppl. 10): 160-163.
9. CAMPBELL AL, HEROLD BC. Immunization of pediatric solid-organ transplantation candidates: immunizations in transplant candidates. Pediatr Transplantation 2005: 9: 6552-6661.
10. GINSBURG C, ANDREWS W. Orthotopic hepatic transplantation for unimmunized children: a paradox of contemporary medical care. Pediatr Infect Dis J 1987: 6: 764-765.
11. THALL T, ROSH J, SCHWERSENZ A, et al. Primary immunization status in infants referred for liver transplantation. Transplant Proc 1994: 26: 191.
12. HIBBERD PL, RUBIN RH. Approach to immunization in the immunosuppressed host. Infect Dis Clin North Am 1990: 4: 123-142.
13. LINNEMAN C, FIRST R, SCHIFFMAN G. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med 1981: 141: 1637-1640.
14. CAREY W, PIMENTEL R, WESTVEER M, VOGT D, BROUGHAN T. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol 1990: 85: 1590-1592.
15. BLUMBERG E, ALBANO C, PRUETT T, ISAACS R, FITZPATRICK J, BERGIN J. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996: 22: 295-302.
16. LOINAZ C, DE JUANES J, GONZALEZ E, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997: 44: 235-238.
17. FLYNN JT, FRISCH K, KERSHAW DB, SEDMAN AB, BUNCHMAN TE. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and receiving peritoneal dialysis. Adv Perit Dial 1999: 15: 269-272.
18. SCHULMAN SL, DEFOREST A, KAISER BA, POLINSKY MS, BALUARTE HJ. Response to measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol 1992: 6: 187-189.
19. WARMINGTON L, LEE BE, ROBINSON JL. Loss of antibodies to measles and varicella following solid organ transplantation in children. Pediatr Transplantation 2005: 9: 311-314.
20. O'SULLIVAN J, DARK J, GOULD K. Haemophilus influenzae immunization and timing of cardiac transplantation. Lancet 1993: 342: 859.
21. HMSO. Immunization against infectious diseases. "The Green Book". London: HMSO, 1996.
22. BILUKHA OO, ROSENSTEIN N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMRW 2005: 54: 1-21.
23. PIROFSKI L-A, CASADEVALL A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Micro Rev 1998: 11: 1-26.
24. SIEGRIST C-A. Understanding immune response to vaccines. Annales Nestle 2000: 58: 75-84.
25. NEUBERGER J. Immunosuppressive drugs. In: MADDERY WC, SORRELL MF, eds. Transplantation of the Liver, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2001; pp. 199-209.
26. BLUMBERG EA, BROZENA SC, STUTMAN P, WOOD D, PHAN HM, MUSHER DM. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis 2001: 32: 307-310.
27. AVERY RK. Immunization in adult immunocompromised patients: which to use and which to avoid. Cleveland Clin J Med 2001: 68: 337-348.
28. BLUMBERG EA, FITZPATRICK J, STUTMAN PC, HAYDEN FG, BROZENA SC. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998: 17: 1075-1080.
29. ELLIS D, GILBOA N, BELLINGER M, et al. Renal transplantation in infants and children. In: SHAPIRO R, SIMMONS RL, STARZEL TE, eds. Renal Transplantation. Stamford: Stapleton and Lange, 1997; p. 461.
30. MOLRINE DC, HIBBERD LP. Vaccines for transplant recipients. Infect Dis Clin North Am 2001: 15: 273-303.
31. BALLONI A, ASSAEL BM, GHIO L, PEDRAZZI HG, et al. Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal and liver transplantation. Vaccine 1999: 17: 2507-2511.
32. GHIO L, PEDRAZZI C, ASSAEL BM, et al. Immunity to diphtheria and tetanus in a young population on dialysis regimen and with renal transplant. J Pediatr 1997: 130: 987-989.
33. ENKE BU, BOKENKAMP A, OFFNER G, BARTMANN P, BRODEHL J. Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients. Transplant 1997: 64: 237-241.
34. NKOWANE B, WASSILAK S, ORENSTEIN W, et al. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 1987: 257: 1335-1340.
35. American Academy of Pediatrics. Poliovirus infections. In: GEORGES MP, ed. 1997 Red Book: Report of the Committee on Infectious Diseases, 24th edn. Elk Grove Village, IL: American Academy of Pediatrics, 1997; pp. 424-433.
36. Centres for Disease Control and Prevention. Notice to readers: recommendations of Advisory Committee on Immunisation Practices: revised recommendations for routine poliomyelitis vaccination. MMWR Morb Mortal weekly Rep 1999: 48: 590.
37. American Academy of Pediatrics Committee on Infectious Diseases. Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. Pediatrics 1999: 103: 171-172.
38. HUZLEY D, NEIFER S, REINKE P, et al. Routine immunization in adult renal transplant recipients. Transplant 1997: 63: 839-845.
39. NEU AM, LEDERMAN HM, WARADY BA, et al. Haemophilus influenzae type b immunization in infants on peritoneal dialysis. Pediatr Peritoneal Nephrol 1996: 70: 84-85.
40. SEVER MS, YILDIZ A, ERAKSOY H, et al. Immune response to Haemophilus influenzae type b vaccination in renal transplant recipients with well-functioning allografts. Nphron 1999: 81: 55-59.
41. VANCE E, GEORGE S, GUINAN EC, et al. Comparison of multiple immunization schedule for Haemophilus influenzae type B-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 1998: 22: 735-741.
42. ROBBINS JB, SCHNEERSON R, ANDERSON P, SMITH DH. The 1996 Albert Lasker medical research awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b: impact on public health and implications for other polysaccharide-based vaccines. JAMA 1996: 276: 1181-1185.
43. KAYHTY H, PELTOLA H, KARANKO V, MAKELA PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983: 147: 1100.
44. AMBER I, GILBERT E, SCHIFFMAN G, JACOBSON J. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation 1990: 49: 122-125.
45. KIND E, CRAFT C, FOWLES J, MCCOY C. Pneumococcal vaccine administration associated with splenectomy: missed opportunities. Am J Infect Control 1998: 26: 418-422.
46. AHMAN H, KAYHTY H, LEHTONEN H, LEROY O, FROESCHLE J, ESKOLA J. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J 1998: 17: 211-216.
47. JACOBSON RM, POLAND GA. The pneumococcal conjugate vaccine. Minerva Pediatr 2002: 54: 295-303.
48. LOTTENBACH KR, MINK CM, BARENKAMP SJ, et al. Age associated differences in immunoglobulin G1(IgG1) and (IgG2) subclass antibodies to pneumococcal polysaccharides following vaccination. Infect Immun 1999: 67: 4935-4938.
49. DENGLER TJ, STMAD N, ZIMMERMANN R, et al. Pneumococcal immunisation after heart and liver transplantation: immune responses in immunosuppressed patients and in healthy controls. DTSCH Med Wchenschr 1996: 121: 1519-1525.
50. FURTH SL, NEU AM, CASE B, et al. Pneumococcal polysaccharide vaccine in children with chronic renal disease: a prospective study of antibody response and duration. J Pediatr 1996: 128: 99-101.
51. FURTH SL, NEU AM, CASE B, et al. Persistence of anticapsular antibody 2 years after pneumococcal vaccine in children with renal disease. J Am Soc Nephrol 1997: 8: 68A.
52. LIN LP, MICHAELS GM, GREEN M, et al. Safety and immunogenicity of American of Academy of Pediatrics - recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics 2005: 116: 160-167.
53. American Academy of Pediatrics, Committee on Infectious Diseases. Policy Statement. Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000: 106: 362-366.
54. Centres for Disease Control and Prevention. Prevention and control of meningococcal disease. Recommendations of the advisory Committee on Immunization Practices. MMWR 2000: 49: 1-20.
55. DE MARTINO M, PODDA A, GALLL L, et al. Acellular petussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection. Vaccine 1997: 15: 1235-1238.
56. CDC. Recommended childhood and adolescent immunization schedule - United States, July-December 2004. MMWR 2004: 53: Q1-Q3.
57. APALSCH A, GREEN M, LEDESMA-MEDINA J, NOUR B, WALD E. Parainfluenza and influenza virus infection in pediatric organ transplant recipients. Clin Infect Dis 1995: 20: 394-399.
58. MAUCH T, BRATTON S, MYERS T, KRANE E, GENTRY S, KASHTAN C. Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics 1994: 94: 225-229.
59. HAYDEN FG. Prevention and treatment of influenza in immunocompromized patients. Am J Med 1997: 120: 55-60.
60. MAUCH T, CROUCH N, FREESE D, et al. Antibody response of paediatric solid-organ transplant recipients to immunization against influenza virus. J Pediatr 1995: 127: 957-960.
61. ADMON D, ENGELHARD D, STRAUSS N, GOLDMAN N, ZAKAY-RONES Z. Antibody response to influenza immunisation in patients after heart transplantation. Vaccine 1997: 15: 1518-1522.
62. EDVARDSSON V, FLYNN J, DEFOREST A, et al. Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant 1996: 10: 556-560.
63. FURTH S, NEU A, MCCOLLEY S, CASE B, STEINHOFF M, FIVUSH B. Immune response to influenza vaccine in children with renal disease. Pediatr Nephrol 1995: 9: 566-568.
64. MACK DR, CHARTRAND SA, RUBY EI, et al. Influenza vaccination following liver transplantation in children. Liver Transplant Surg 1996: 2: 431-437.
65. DENGLER TJ, STRNAD N, BUHRING I, et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 1998: 66: 1340-1347.
66. SOESMAN NMR, RIMMELZWAAN GF, NIEUWKOOP NJ, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000: 61: 85-93.
67. VERSLUIS DJ, BEYER WEP, MASUREL N, WENTING GJ, WEIMAR W. Impairment of the immune response to influenza vaccination in renal transplant recipients by ciclosporine, but not azathioprine. Transplantation 1986: 42: 376-379.
68. American Academy of Pediatrics. Influenza. In: GEORGES MP, ed. 1997 Red Book: Report of the Committee on Infectious Diseases, 24th edn. Elk Grove Village, IL: American Academy of Pediatrics, 1997; pp. 307-315.
69. HARPER AS, FUKUDA K, UYEKI MT, COX JN, BRIDGES BC. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005: 54: 1-40
70. BELLE S, BERINGER K, DETRE K. An update on liver transplantation in the United states: recipient characteristics and outcome. Clin Transpl 1995: 37: 19-33.
71. American Academy of Pediatrics. Hepatitis B. In: GEORGES MP, ed. 1997 Red Book: Report of the Committee on Infectious Diseases, 24th edn. Elk Grove Village, IL: American Academy of Pediatrics, 1997; pp. 247-260.
72. BONANNI P. Universal hepatitis B immunization: infants, infants plus adolescent immunization. Vaccine 1998: 16: S17-S22.
73. DODDSON S, ISSA S, BONHAM A. Liver transplantation for chronic viral hepatitis. Surg Clin North Am 1999: 79: 131-145.
74. FABIA R, LEVY MF, CRIPPIN J, et al. De novo hepatitis B infection after liver transplantation source of disease, incidence and impact. Liver Transplant Surg 1998: 4: 119-127.
75. VILLENEUVE E, VINCELETTE J, VILLENEUVE JP. Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation. Can J Gastroenterol 2000: 14: 59B-62B.
76. KALLINOWSKI B, BENZ C, BUCHHOLZ L, STREMMEL W. Accelerated schedule of hepatitis B vaccination in liver transplant candidates. Transplant Proc 1998: 30: 797-799.
77. ROSMAN AS, BASU P, GALVIN K, LIEBER CS. Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomised clinical trial. Am J Med 1997: 103: 217-222.
78. HORLANDER JC, BOYLE N, MANAM R, et al. Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation. Am J Med Sci 1999: 318: 304-307.
79. ARSLAN M, WIESNER RH, SIEVERS C, EGAN K, ZEIN NN. Double dose accelerated hepatitis vaccine in patients with end stage liver disease. Liver Transplantation 2001: 7: 314-320.
80. WATKINS SL, ALEXANDER SR, BREWER ED, et al. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 2002: 40: 365-372.
81. FOSTER P, HOOD K, GRANT C, et al. Accelerated protocol of vaccination against hepatitis B prior to liver transplantation. Transplantation 1998: 65: S186.
82. TEPERMAN L, MORGAN G, DIFLO T, et al. Accelerated triple dose hepatitis B vaccination is successful in cirrhotic patients. Transplantation 1999: 67: S17.
83. BOSNAK M, DIKICI B, BOSNAK V, HASPOLAT K. Accelerated hepatitis B vaccination schedule in childhood. Pediatr Int 2002: 44: 663-665.
84. WILLER IR, UHL MD, HAWARD CS, et al. Serious hepatitis A: an analysis of patients hospitalised during an urban epidemic in the United States. Ann Intern Med 1998: 128: 111-114.
85. STARK K, GUNTHER M, NEUHAUS R, et al. Immunogenicity and safety of hepatitis A vaccination in liver and renal transplant recipients. J Infect Dis 1999: 180: 2014-2017.
86. GUNTHER M, STARK K, NEUHAUS R, et al. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 2001: 71: 477-479.
87. ARGUEDAS MR, JOHNSON A, ELOUEIDI MA, FALLON MB. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients. Hepatology 2001: 34: 28-31.
88. BELL PB, WASLEY A, SHAPIRO NC, MARGOLES SH. CDC, Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999: 48: 1-37.
89. HORNG YC, CHANG MH, LEE CY, SAFARY A, ANDRE FE, CHEN DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis 1993: 12: 359-362.
90. American Academy of Pediatrics. Hepatitis. In: GEORGES MP, ed. 1997 Red book: Report of the Committee on Infectious Diseases, 24th edn. Elk Grove Village, IL: American Academy of Pediatrics, 1997; pp. 237-246.
91. FURTH SL, SULLIVAN EK, NEU AM, TEJANI A, FIVUSH BA. Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1997: 1: 37-42.
92. ZAMORA I, SIMON JM, DA SILVA ME, PIQUERAS AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol 1994: 8: 190-192.
93. CHAVES TSS, LOPES MH, UEDA VA, et al. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients. Pediatr Transplantation 2005: 9: 192-196.
94. BROYER M, TETE MJ, GUEST G, GANGNADOUX MF, ROUZIOUX C. Varicella and zoster after kidney transplantation: long term results of vaccination. Pediatrics 1997: 99: 35-39.
95. GERSHON AA, STEINBERG S. Persistence of immunity to varicella in children with leukaemia immunized with live attenuated varicella virus. N Engl J Med 1989: 320: 892-897.
96. WARMINGTON L, LEE BE, ROBINSON JL. Loss of antibodies to measles and varicella following solid organ transplantation in children. Pediatr Transplantation 2005: 9: 311-314.
97. RAND EB, MCCARTHY CA, WHITINGTON PF. Measles vaccination after orthotopic liver transplantation. J Pediatr 1993: 1123: 87-89.
98. BAKSHI N, LAWSON J, HANSON R, AMES C, VINTERS HV. Fatal mumps meningoencephalitis in a child with severe combined immunodeficiency after bone marrow transplantation. J Child Neurol 1996: 11: 159-162.
99. MAZARIEGOS GV, GREEN M, REYES J, et al. Rubella infection after orthotopic liver transplantation. Pediatr Infect Dis J 1994: 13: 161-162.
100. KINGS M, SAUNDERS EF, PETRIC M, GOLD R. Response to measles, mumps and rubella vaccine in pediatric bone marrow transplant recipients. Bone Marrow Transplant 1996: 17: 633-636.
101. ACIP. Update: vaccine side effects, adverse reactions, contraindications, and precautions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996: 45: 1-35.
102. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994: 43: RR-1.
103. Centers for Disease Control and Prevention. Immunization of health care workers: recommendations of Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee. MMWR 1997: 46: 1-42.
104. Centres for Disease Control and Prevention. Recommendations for using smallpox vaccine in a pre-event vaccination program. MMWR 2003, 52: 1-16.
105. DAZ PS, AU D, SMITH S, AMYLON M, LINK M, ARVIN AM. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Pediatrics 1991: 87: 166-170.
106. Centers for Disease Control and Prevention. Recommendations of Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 1993: 42: RR-4.